Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengchao Yan

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|October 28, 2023
The Dual-Mode Transition of Myofibroblasts Derived from Hepatic Stellate Cells in Liver FibrosisMengchao Yan, Ye Xie, Jia Yao, et al.
Biomed Research International|November 29, 2021
The Potential of Mesenchymal Stem Cells for the Treatment of Cytokine Storm due to COVID-19Xun Li, Mengchao Yan, Jun Chen, et al.
Biofabrication|March 5, 2024
Bioreactor-based stem cell therapy for liver fibrosisMengchao Yan, Jia Yao, Ye Xie, et al.
Acta Biomaterialia|August 10, 2022
The role of matrix stiffness in cancer stromal cell fate and targeting therapeutic strategiesJiayun Wei, Jia Yao, Mengchao Yan, et al.
Journal of Translational Medicine|November 19, 2023
Pretreatment of UC-MSCs with IFN-α2 improves treatment of liver fibrosis by recruiting neutrophilsYe Xie, Jia Yao, Mengchao Yan, et al.
Journal of Translational Medicine|March 18, 2023
Tumor cell density dependent IL-8 secretion induces the fluctuation of tregs/CD8 + T cells infiltration in hepatocellular carcinoma: one prompt for the existence of density checkpointMengchao Yan, Jia Yao, Yan Lin, et al.
Journal of Nanobiotechnology|October 1, 2022
Huc-MSC-derived exosomes modified with the targeting peptide of aHSCs for liver fibrosis therapyYan Lin, Mengchao Yan, Zhongtian Bai, et al.
European Journal of Pharmacology|August 10, 2024
Baicalin ameliorates angiotensin II-induced cardiac hypertrophy and mitogen-activated protein kinase signaling pathway activation: A target-based network pharmacology approachYing Cheng, Guosheng Lin, Yi Xie, et al.
Journal of Translational Medicine|December 3, 2022
Heterogeneous matrix stiffness regulates the cancer stem-like cell phenotype in hepatocellular carcinomaJiayun Wei, Jia Yao, Chendong Yang, et al.
Biochemical Pharmacology|March 18, 2026
Lin28A Drives hepatic fibrosis by suppressing HMGA2/HIF-1α-Dependent ferroptosis in hepatic stellate cellsAnkang Wang, Hongfa Sun, Haixia Zhao, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|October 28, 2023
The Dual-Mode Transition of Myofibroblasts Derived from Hepatic Stellate Cells in Liver FibrosisMengchao Yan, Ye Xie, Jia Yao, et al.
Biomed Research International|November 29, 2021
The Potential of Mesenchymal Stem Cells for the Treatment of Cytokine Storm due to COVID-19Xun Li, Mengchao Yan, Jun Chen, et al.
Biofabrication|March 5, 2024
Bioreactor-based stem cell therapy for liver fibrosisMengchao Yan, Jia Yao, Ye Xie, et al.
Acta Biomaterialia|August 10, 2022
The role of matrix stiffness in cancer stromal cell fate and targeting therapeutic strategiesJiayun Wei, Jia Yao, Mengchao Yan, et al.
Journal of Translational Medicine|November 19, 2023
Pretreatment of UC-MSCs with IFN-α2 improves treatment of liver fibrosis by recruiting neutrophilsYe Xie, Jia Yao, Mengchao Yan, et al.
Journal of Translational Medicine|March 18, 2023
Tumor cell density dependent IL-8 secretion induces the fluctuation of tregs/CD8 + T cells infiltration in hepatocellular carcinoma: one prompt for the existence of density checkpointMengchao Yan, Jia Yao, Yan Lin, et al.
Journal of Nanobiotechnology|October 1, 2022
Huc-MSC-derived exosomes modified with the targeting peptide of aHSCs for liver fibrosis therapyYan Lin, Mengchao Yan, Zhongtian Bai, et al.
European Journal of Pharmacology|August 10, 2024
Baicalin ameliorates angiotensin II-induced cardiac hypertrophy and mitogen-activated protein kinase signaling pathway activation: A target-based network pharmacology approachYing Cheng, Guosheng Lin, Yi Xie, et al.
Journal of Translational Medicine|December 3, 2022
Heterogeneous matrix stiffness regulates the cancer stem-like cell phenotype in hepatocellular carcinomaJiayun Wei, Jia Yao, Chendong Yang, et al.
Biochemical Pharmacology|March 18, 2026
Lin28A Drives hepatic fibrosis by suppressing HMGA2/HIF-1α-Dependent ferroptosis in hepatic stellate cellsAnkang Wang, Hongfa Sun, Haixia Zhao, et al.
Pageof 2